PDCD1LG2 and myeloid sarcoma: Blocking PD-L1 and PD-L2 in EAE, the mouse model of MS, leads to earlier onset and increased severity of the disease, mainly due to elevated number of infiltrating immune cells, especially CD8 T cells [25,26].